Occupational exposures to illicit drugs in forensic science divisions, urine analysis
ID: 75D30123P17756Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFCENTERS FOR DISEASE CONTROL AND PREVENTIONCDC OFFICE OF ACQUISITION SERVICESATLANTA, GA, 30333, USA

NAICS

Colleges, Universities, and Professional Schools (611310)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)
Timeline
    Description

    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source contract to the University of California, San Francisco (UCSF) for urine analysis services related to occupational exposures to illicit drugs in forensic science divisions. The contract aims to analyze urine samples for substances such as cocaine, fentanyl, heroin, and methamphetamine, utilizing UCSF's specialized liquid chromatography-tandem mass spectrometry (LC-MS/MS) technology, which provides the lowest achievable detection limits for these drugs. This procurement is critical for addressing significant gaps in knowledge regarding the health risks faced by forensic science workers who may be exposed to these hazardous substances, with the contract period set from March 1, 2024, to February 28, 2027. Interested parties may submit their interest and capability to respond to this requirement by emailing Laurie Presley at xnp0@cdc.gov by 1:00 PM Eastern Time on November 15, 2024.

    Point(s) of Contact
    Laurie Presley
    xnp0@cdc.gov
    Files
    Title
    Posted
    The document outlines a justification for a sole source procurement by the National Institute for Occupational Safety and Health (NIOSH) for urine analysis services provided by the University of California, San Francisco (UCSF). The procurement is categorized under a sole source acquisition due to UCSF's unique capability in employing liquid chromatography-tandem mass spectrometry (LC-MS/MS) to detect low-level illicit drugs, including cocaine and fentanyl, which meets specific detection requirements not available elsewhere. The justification includes the need for increased urine sample analyses over the next option years. The document complies with Federal Acquisition Regulation (FAR) guidelines accommodating situations where only one vendor can fulfill the requirements efficiently and with the necessary quality. It also emphasizes the urgency and specialized nature of the services, presenting UCSF as the only vendor capable of delivering the analyses within the required timeframe. The program office conducted market research, ruling out other potential vendors, confirming UCSF's proprietary technology as essential for their operational needs. Both the program and contracting offices certified the justification's accuracy and necessity.
    Similar Opportunities
    CDC DFWED NARST Sensititre Supplies
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) is seeking to award a sole source contract for antimicrobial resistance testing supplies, specifically Sensititre™ broth microdilution testing products, from ThermoFisher Scientific. This procurement is essential for the National Antimicrobial Resistance Monitoring System (NARMS), which has utilized these proprietary materials since 1996 to ensure a standardized approach to monitoring enteric bacteria resistance. The unique nature of these supplies necessitates this sole source approach, as alternatives would require significant investments in new equipment and validation processes, potentially disrupting critical surveillance efforts. Interested parties may respond within 15 days to express their interest, with proposals directed to contract specialist Ashley Williams at dal3@cdc.gov.
    Diagnostic Test Development and Production for Emergency Response
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking contractors for the development and production of diagnostic tests aimed at enhancing emergency response capabilities for public health threats. The procurement involves a range of tasks, including the rapid development and validation of Nucleic Acid Amplification Tests for selected pathogens, regulatory submissions for Emergency Use Authorization (EUA) or 510(k) approval, and the manufacturing of tests to meet outbreak demands. This initiative is critical for bolstering the national laboratory system's readiness and efficiency in addressing public health emergencies. Proposals are due by December 2, 2024, with a maximum contract value of $148 million and a minimum order of $10,000. Interested parties can contact Shayna Connery at xvj9@cdc.gov or (404) 498-0715 for further information.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Control (CMC) services related to the development of drug substances under RFP number 75N95024R00094. The primary objective is to secure high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, ensuring compliance with current Good Manufacturing Practices (cGMP). This initiative is crucial for advancing therapeutic innovations and facilitating collaborations in drug development, with a total funding amount of up to $49.7 million anticipated over the contract period from September 1, 2025, to May 14, 2031. Interested parties should direct inquiries to Samson Shifaraw at samson.shifaraw@nih.gov or Valerie Whipple at valerie.whipple@nih.gov, and submit proposals by the deadline of December 3, 2024.
    Hologic Equipment Maintenance Service Contract
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to issue a sole source contract for a one-year Hologic Equipment Maintenance Service Agreement, with the possibility of extensions, to ensure the proper functioning of critical laboratory equipment used in HIV research. The contract will require the contractor to provide preventive maintenance, repairs, and necessary parts exclusively from Hologic, Inc., the sole manufacturer of the Panther systems essential for HIV testing, emphasizing the urgency and proprietary nature of the services needed. This procurement is vital for maintaining high standards in laboratory operations that support public health outcomes, with a response deadline for interested parties set for November 19, 2024, at 1:00 P.M. ET. Interested vendors must contact Stephanie Reid at qsi5@cdc.gov and be registered in the System for Award Management (SAM) to participate.
    Notice of Intent to Sole Source to Bruker Scientific LLC
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to Bruker Scientific, LLC for an annual maintenance agreement for the Bruker MALDI Biotyper Sirius One Instrument, which is critical for the Clinical and Environmental Microbiology Branch in Atlanta, Georgia. This contract, governed by Federal Acquisition Regulation for sole source acquisitions, will provide comprehensive service coverage essential for maintaining accuracy in bacterial analysis and ensuring compliance with clinical regulations. As the Original Equipment Manufacturer (OEM), Bruker is uniquely qualified to service this complex instrument, and market research has confirmed that no alternative providers are available. The anticipated award date is November 26, 2024, and interested vendors may contest this sole source designation by contacting Kenyadah M. Gamble at xvw0@cdc.gov or Philip Denis at icx2@cdc.gov before the specified deadline.
    Notice of Intent to Sole Source to Ecolab, Inc.
    Active
    Health And Human Services, Department Of
    The Centers for Disease Control and Prevention (CDC) intends to award a sole source contract to Ecolab, Inc. for the annual preventative maintenance of the Bioquell QUBE Mark IV Aseptic Processing Workstation. This contract is essential to ensure operational integrity for critical clinical testing in biopharmaceutical applications, as Ecolab is the original manufacturer and the only authorized provider capable of servicing this specialized equipment. The maintenance services will include recalibrations, software upgrades, and responsive service to minimize laboratory downtime, thereby supporting the CDC's compliance with its Quality Management System policies. The contract is structured for one base year with three optional one-year extensions, with an anticipated start date of November 26, 2024. For further inquiries, interested parties may contact Kenyadah M Gamble at xvw0@cdc.gov or Philip Denis at icx2@cdc.gov.
    Notice of Intent to Award Sole Source
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), intends to award a sole source contract to Metro Health for access to the Epic Cosmos electronic health record dataset. This dataset, which encompasses electronic health records from over 240 million patients across all 50 states, is crucial for assessing real-world effectiveness questions, particularly regarding rare health outcomes, due to its real-time updates and comprehensive features. Interested parties may express their interest and capability to respond to this requirement within fifteen days of this notice, with all communications directed to contract specialist Peter Loree at zus0@cdc.gov. This procurement is not open for competitive quotations, and the government retains discretion over whether to pursue competitive procurement based on the responses received.
    Service/Maintenance Agreement for the Agilent instrumentation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to establish a service and maintenance agreement for Agilent instrumentation utilized at the National Center for Advancing Translational Sciences (NCATS). This procurement aims to ensure the operational integrity and performance of Agilent Liquid Chromatography/Mass Spectrometry (LCMS) systems, which are critical for various research applications, including high-throughput mass spectrometry analysis. The contract, valued at an estimated amount not exceeding $7.5 million, is intended to be awarded on a sole-source basis to Agilent Technologies Inc., as they are the only authorized provider capable of maintaining these systems without voiding existing warranties. Interested parties must submit their capabilities and proposals by November 22, 2024, to Patricia da Silva at patricia.dasilva@nih.gov.
    PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), is seeking proposals for the "Preparation and Distribution of Research Drug Products" under solicitation number 75N95024R00003. The primary objective of this procurement is to acquire, analyze, create, and distribute a variety of drug compounds essential for drug abuse and addiction research, including controlled and uncontrolled substances, while ensuring compliance with DEA regulations. This contract, structured as an indefinite delivery, indefinite quantity (IDIQ) agreement for a five-year period, aims to enhance research capabilities in the field of drug abuse, with proposals due by November 15, 2024, at 1:00 PM (Eastern Time). Interested parties should contact Scott Duernberger at scott.duernberger@nih.gov or Josh Lazarus at josh.lazarus@nih.gov for further information.
    R--FBO Foe FASD Coordinator
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to serve as the FASD Coordinator for a project focused on analyzing a master dataset from 16 studies related to Fetal Alcohol Spectrum Disorder (FASD). The contractor will be responsible for data cleaning, integration, hypothesis testing, and statistical analysis, under the supervision of Dr. Julie Kable from Emory University, and will also provide training to NIAAA fellows on data analysis methods. This project is critical for understanding the impacts of prenatal alcohol exposure, which often leads to undiagnosed physical and cognitive impairments in affected individuals. Interested bidders must register with SAM and submit their technical and price quotations by November 26, 2024, for the contract period running from December 1, 2024, to November 30, 2025. For further inquiries, contact Michael L. Falzone at falzoneml@nih.gov or +1 301 827 1873.